Lixte Biotechnology Holdings, Inc. Common Stock

LIXT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

87M

Short interest (May 15)

0.6%

Net Short (Jun 03 ): 0.0%

Borrow Fee

14.69%

↑ 24.3%

Available Shares

100K

↓ 64.7%

Price Chart

Company Overview

Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001335105

Asset Type: CS

Market Data

Market Cap: $87,175,925

Employees: 3

Status: Active

Short Interest

Current Borrow Fee 14.69%

Range: 14.69% - 17.94%

Available Shares 100K

Range: 85K - 100K

Recent Changes

Fee Change: ↑ 34.2%

Available Change: ↑ 66.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime